Latest Breaking News On - Minvest partners - Page 6 : comparemela.com

Canaccord Genuity Group Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $107 00

Canaccord Genuity Group Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $107 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJoels marcusNeedham companySecurities exchange commissionPhocas financial corpCantor fitzgeraldHealthcare of ontario pension plan trust fundCanaccord genuity groupRoyal bankQuantum private wealthCellular therapies incCharles schwab investment management incIntra cellular therapiesFree reportGenuity groupModerate buy

Neurocrine Biosciences, Inc (NASDAQ:NBIX) Holdings Lifted by Larson Financial Group LLC

Neurocrine Biosciences, Inc (NASDAQ:NBIX) Holdings Lifted by Larson Financial Group LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesIngrid delaetNeurocrine biosciencesZurcher kantonalbank zurich cantonalbankDavidw boyerLarson financial groupHoldings channelRoman butler fullerton coNeurocrine biosciences incRedhawk wealth advisors incCantor fitzgeraldFree reportFinancial groupWealth advisorsMinvest partnersButler fullerton

Calamos Advisors LLC Cuts Stock Position in Centene Co (NYSE:CNC)

Calamos Advisors LLC reduced its position in Centene Co. (NYSE:CNC – Free Report) by 1.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 126,019 shares of the company’s stock after selling 1,646 shares during the quarter. Calamos Advisors LLC’s holdings in Centene were […]

United statesZurcher kantonalbank zurich cantonalbankKennethj fasolaLivforsakringsbolaget skandia omsesidigtLori jean robinsonWells fargo companyDaiwa securities group incCantor fitzgeraldCalamos advisorsArcher investment corpCentene coExchange commissionSecurities exchange commissionCentene company profileCentene corporationFree report

Tyche Wealth Partners LLC Takes $420,000 Position in Gilead Sciences, Inc (NASDAQ:GILD)

Tyche Wealth Partners LLC bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,181 shares of the biopharmaceutical company’s stock, valued at approximately $420,000. Several other large […]

United statesMerdad parseyComplera evipleraZurcher kantonalbank zurich cantonalbankGilead sciences increases dividendTyche wealth partnersGilead sciences company profileExchange commissionOctavia wealth advisorsGilead sciences stock downNews ratings for gilead sciences dailyGilead sciences incGilead sciencesWealth allianceRoyal bankCantor fitzgerald

NBW Capital LLC Reduces Position in Boston Scientific Co (NYSE:BSX)

NBW Capital LLC lessened its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 0.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 104,139 shares of the medical equipment provider’s stock after selling 774 shares during the period. […]

United statesEdwardj ludwigWendy carruthersLivforsakringsbolaget skandia omsesidigtRaymond jamesBoston scientific company profileDaiwa securities group incExchange commissionEverence capital management incBoston scientificBoston scientific corporationCapital management incBoston scientific coNeedham companyJpmorgan chase coNbw capital